Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia

Annals of the Rheumatic Diseases

Volumn 62, Issue 6, 2003, Pages 551-555

  Ozgocmen, S ^a   Yoldas, T ^a   Kamanli, A ^a   Yildizhan, H ^a   Yigiter, R ^a   Ardicoglu, O ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; EVALUATION; EVOKED AUDITORY RESPONSE; FEMALE; FIBROMYALGIA; HUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; CASE-CONTROL STUDIES; EVENT-RELATED POTENTIALS, P300; FEMALE; FIBROMYALGIA; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; PAIN THRESHOLD; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0038147269     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.6.551     Document Type: Article

References (37)

1. Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
2. Clauw DJ. Fibromyalgia. In: Ruddy S, Harris ED, Sledge CB, eds. Kelly's textbook of rheumatotogy. 6th ed. Philadelphia: Sounders, 2001:417-27.
3. Ozgocmen S, Cimen OB, Ardicoglu O. Relationship between chest expansion and respiratory muscle strength in patients with primary fibromyalgia. Clin Rheumatol 2002;21:19-22.
4. Gut A, Karakoc M, Nas K, Cevik R, Denli A, Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002;29:358-61.
5. Sletvold H, Stiles TC, Landro NI. Information processing in primary fibromyalgia, major depression and healthy controls. J Rheumatol 1995;22:137-42.
6. Landro NI, Stiles TC, Slehvold H. Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 1997;42:297-306.
7. Grace GM, Nielson WR, Hopkins M, Berg MA. Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 1999;21:477-87.
8. Park DC, Glass JM, Minear M, Crofford U. Cognitive function in fibromyalgia patients. Arthritis Rheum 2001;44:2125-33.
9. Glass JM, Park DC. Cognitive dysfunction in fibromyalgia. Curr Rheumatol Rep 2001;3:123-7.
10. Tachibana H, Toda K, Sugida M. Age-related changes in attended and unattended P3 latency in normal subjects. Int J Neurosci 1992;66:277-84.
11. Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol 1998;15:14-33.
12. Polich J, Herbst KL. P300 as a clinical assay: rationale, evaluation and findings. Int J Psychophysiol 2000;38:3-19.
13. Dochin E, Cobs MGN. Is the P300 component a manifestation of context updating? Behav Brain Sci 1988;11:357-74.
14. Nagasawa T, Kamiya T, Kawasaki Y, Higashima M, Urata K, Sakai N, et aL The relationship between auditory ERP and neuropsychoyogical assessment in schizophrenia. Int J Psychophysiol 1999;34:267-74.
15. Korpelainen JT, Kauhanen ML, Tolonen U, Brusin E, Mononen H, Hiltunen P, et al. Auditory P300 event related potential in minor ischemic stroke. Acta Neurol Scand 2000;101:202-8.
16. Partin R, Kovala T, Polo-Kantola P, Revonsuo A, Muller K, Matikainen E. Does P3 reflect attentional or memory performance, or cognition more generally? Scand J Psychol 2000;41:31-40.
17. Catal SA, Erdem HR, Okumus M, Ozgocmen S, Yorgancioglu Y.R. The measurement of pain pressure threshold in patients with rheumatoid arthritis. Pain Clinic 2000;12:187-91.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
20. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12
21. Leavitt F, Katz RS, Mills M, Heard AR. Cognitive and dissociative manifestations in fibromyalgia. J Clin Rheumatol 2002;8:77-84
22. Starlanyl DJ, Copeland ME. Fibromyalgia and chronic myofascial pain: a survival manual. 2nd ed. Oakland, CA: New Harbinger Publications, 2001:199-208.
23. Segalowitz S, Barnes K. The reliability of ERP components in the auditory oddball paradigm. Psychophysiology 1993;30:451-9.
24. Taghavy A, Kugler CFA. The pattern flash elicited P300 potentials (PF-P300): a new method for studying cognitive processes of the brain. Int J Neurosci 1988;38:179-88.
25. Weissenborn K, Wiltfang J, Schmidt FW, Kunkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 1990;75:289-95.
26. Polich J, Kok A. Cognitive and biological determinants of P300: an integrative review. Biol Psychol 1995;41:103-46.
27. Polich J. P300 in clinical applications. Meaning, method and measurement. Am J EEG Technol 1991;31:201-31.
28. Geisler M, Polich J. P300 and time of day: circadian rhythms, food intake and body temperature. Biol Psychol 1990;31:1-20.
29. Geisler M, Polich J. P300, food consumption, and memory performance. Psychophysiology 1992;29:76-85.
30. Kugler CFA, Taghavy A, Platt D. The event-related P300 potential analysis of cognitive human brain aging: a review. Gerontology 1993;39:280-303.
31. Kugler CFA Petter J, Platt D. Age-related dynamics of cognitive brain functions in humans: an electrophysiologica/approach. J Gerontol Biol Sci 1996;51A:B3-16.
32. Gervais RO, Russell AS, Green P, Allen LM III, Ferrari R, Pieschl SD. Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol 2001;28:1892-9.
33. Newhouse PA, Krishnan K, Doraiswamy P, Richter EM, Batzar ED, Clary CM. A double- blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000;61:559-68
34. Meador KJ. Cognitive side effects of medications. Neurol Clin 1998;16:141-55
35. Sanz M, Molina V, Martin-Loeehes M, Calcedo A, Rubia FJ. Auditory P300 event-related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients. Psychiatry Res 2001;101:75-81.
36. Seifritz E, Moore P, Trachsel L, Bhatti T, Stahl SM, Gillin JC. The 5-HTIA agonist ipsaprione enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Lett 1996;209:41-4.
37. Young AH, Hughes JH, Marsh VR, Ashton CH. Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: a preliminary study. J Affect Disord 2002;69;83-92.